Interventions for valvular disease
Early experience with a purpose-designed temporary pacing guidewire for transcatheter valve implantation August 9, 2019 | 10.4244/EIJ-D-19-00138
Showing 1-12 of 12 articles
Interventions for valvular disease
Impact of implant depth on hydrodynamic function with the ACURATE neo transcatheter heart valve following valve-in-valve transcatheter aortic valve replacement in Mitroflow bioprosthetic valves: an ex vivo bench study May 20, 2019 | 10.4244/EIJ-D-18-00947
Increasing awareness of the need to protect the coronary arteries in patients with failed surgical and transcatheter aortic valves
May 20, 2019 | 10.4244/EIJV15I1A3
Interventions for valvular disease
First-in-human experience of a new-generation transfemoral transcatheter aortic valve for the treatment of severe aortic regurgitation: the J-Valve transfemoral system February 7, 2019 | 10.4244/EIJ-D-18-00935
Novel strategies in aortic valve-in-valve therapy including bioprosthetic valve fracture and BASILICA
September 7, 2018 | 10.4244/EIJ-D-18-00667
Transcatheter or surgical valve replacement: which strategy when bioprosthetic valves fail?
November 20, 2017 | 10.4244/EIJV13I10A177
Interventions for valvular disease
Transcatheter aortic valve replacement with the Portico valve: one-year results of the early Canadian experience January 20, 2017 | 10.4244/EIJ-D-16-00299
Interventions for valvular disease
In vitro evaluation of implantation depth in valve-in-valve using different transcatheter heart valves September 18, 2016 | 10.4244/EIJV12I7A149
Impact of low-profile sheaths on vascular complications during transfemoral transcatheter aortic valve replacement
December 27, 2013 | 10.4244/EIJV9I8A156
Edwards SAPIEN 3 valve
September 30, 2012 | 10.4244/EIJV8SQA15
Valve thrombosis after transcatheter heart valve implantation
May 17, 2011 | 10.4244/EIJV7I1A28
